TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers analyzing validated records estimated that 13.83% of women in Bolotana, Sardinia, who reached age 70 during the 2021–2025 analysis would survive to 100, a rate more than three times the contemporary Italian, Sardinian and Nuoro Province comparisons. The authors describe Bolotana as a promising blue-zone candidate, not an established longevity hotspot; estimates changed substantially across calendar periods, and the study did not formally test differences between populations.
A study of Bolotana, Sardinia, estimates that women who reached age 70 during 2021–2025 had a 13.83% chance of surviving to 100—more than three times the corresponding estimates for Nuoro Province, Sardinia and Italy. Published in Frontiers in Aging, the research identifies the mountain village as a possible new longevity hotspot, while noting that results varied across time periods and do not establish Bolotana as a confirmed blue zone.
The researchers built separate life tables for women and men using records for residents aged 70 and older. For women, estimated remaining life expectancy at age 70 was 20.85 years, compared with 18.61 years in Nuoro Province, 18.40 years in Sardinia and 18.06 years across Italy. These are descriptive comparisons; the authors did not run formal statistical tests to determine whether the differences between populations were significant.
The analysis covered 3,138 person-years of observation and 149 deaths from 2021 to 2025. Bolotana’s average resident population during those years was 2,266. To check ages, the team compared civil records with baptism and burial records from parish archives. Civil birth records were available for every identified centenarian, and researchers independently checked 97% of centenarian deaths against parish records.
The study also examined a separate cohort of 3,060 people born in Bolotana between 1900 and 1925, including people who later moved away. Researchers tested alternative assumptions and other calendar periods, including 2015–2019 and 2020–2025. The reported female survival advantage differed markedly across periods, a qualification that limits what can be concluded from the headline estimate.
A Possible Longevity Cluster Outside Nuoro
Bolotana lies about 110 kilometers from Sardinia’s original blue zone, a cluster of 14 mountain municipalities in the Nuoro and Ogliastra areas. The finding matters because it suggests that unusually high survival in old age may warrant investigation beyond the places already associated with Sardinian longevity. If confirmed over time, Bolotana could provide another population for research into survival at advanced ages.
The result is a demographic signal, not an explanation. The study does not establish why women in the village had higher estimated survival, nor does it show that a particular diet, lifestyle or local practice caused the difference. Its value is in identifying a candidate for further study using validated records, while making clear that comparisons and time-period sensitivity need careful interpretation.
Products Worth Considering
OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG
OMRON VIVA 360+ Body Composition Monitor and Smart Scale
Garmin Forerunner 165 GPS Running Smartwatch, 43 mm, Black
As an affiliate, we earn on qualifying purchases.
How Bolotana Differs From the Original Zone
Blue zones are geographically defined areas associated with unusually favorable survival into late life and relatively high numbers of people reaching 100. Sardinia’s historically recognized zone includes 14 mountain municipalities. Researchers have debated how durable reported advantages in various longevity regions are, since outcomes can change as survival improves elsewhere and as different birth cohorts age.
Claims about exceptional longevity also depend on reliable ages. Researchers can misclassify apparent centenarians if records are incomplete or ages are reported inaccurately. In this study, the team used civil and parish archives to check ages and deaths, then compared Bolotana’s recent estimates with published data from the Italian National Institute of Statistics and the Human Mortality Database. The comparisons were descriptive rather than formal tests.
The study’s authors included researchers from Sardinian and US institutions. The paper disclosed that coauthor Dan Buettner owns Blue Zones, Inc., and that S. Jay Olshansky received consulting compensation connected to a proposed Blue Zone Research Institute. These disclosures provide relevant information about potential interests; they do not, on their own, determine whether the findings are valid.
“a promising blue-zone candidate rather than an established longevity hotspot”
— The study authors
Why the Survival Estimate May Change
The 13.83% estimate applies to the 2021–2025 analysis, and sensitivity analyses found that the estimated advantage differed markedly in other calendar periods. The supplied report does not give the alternative period-specific female survival estimates, so the size and direction of those differences cannot be compared here. The authors also did not conduct formal statistical tests between Bolotana and the regional or national comparison groups.
The findings do not identify a cause for the apparent advantage or establish whether it will persist. The source material reports an analysis for both sexes but does not provide the corresponding detailed results for Bolotana men. It also does not give a confidence interval for the 13.83% estimate in the available summary. These limits mean the result should be read as a finding that merits follow-up, not proof that the village has a stable, exceptional longevity pattern.
Further Records and Period Comparisons
The published analysis lays out a basis for additional demographic research, including examining Bolotana across longer time spans and checking whether the female survival pattern holds for other cohorts. Researchers can also investigate how results change with alternative mortality assumptions and compare any new estimates against updated regional and national data.
No follow-up study or next publication date is specified in the supplied report. Until further evidence is available, the appropriate conclusion is limited: validated local records point to unusually high estimated survival among older women during 2021–2025, but the period sensitivity and lack of formal population-level tests leave Bolotana’s status as a blue zone unresolved.
Key Questions
What did the Bolotana study find?
For 2021–2025, the researchers estimated that 13.83% of women at age 70 would survive to 100. They also estimated female life expectancy at age 70 at 20.85 additional years. These figures are study estimates, not guarantees for individuals.
Is Bolotana officially a blue zone?
No. The study presents Bolotana as a promising candidate, not an established longevity hotspot. The estimated advantage varied across the calendar periods examined.
How did researchers check ages?
The team cross-checked civil records against historical parish baptism and burial records. Civil birth documentation was available for every identified centenarian, and 97% of recorded centenarian deaths were independently checked against parish archives.
How does the female survival estimate compare with Italy?
The estimated 13.83% survival from age 70 to 100 was more than three times the reported comparison for Italy, 3.54%, as well as the figures for Sardinia and Nuoro Province. The authors did not formally test the differences between these populations.
What remains unknown?
The study does not establish why the estimated survival advantage appeared, whether it will continue, or whether Bolotana meets a consistent definition of a blue zone. Its results also differed across calendar-period sensitivity analyses.
Source: news-medical.net
